Treatment of Allergic Rhinitis in Elderly Patients with Cardiovascular and Renal Issues

Introduction to Antihistamine Selection

The American Academy of Allergy, Asthma, and Immunology recommends second-generation antihistamines over first-generation antihistamines for elderly patients with heart and kidney issues due to their favorable safety profile and lack of sedation at recommended doses 1, 2, 3
First-generation antihistamines have significant risks for elderly patients, including increased sensitivity to psychomotor impairment, higher risk of falls, fractures, and subdural hematomas, and greater susceptibility to anticholinergic effects 1

Fexofenadine is the preferred second-generation antihistamine for elderly patients with cardiovascular and renal issues because it has no sedation even at higher than FDA-approved doses, no significant cardiovascular concerns, and is less affected by renal impairment compared to other options 1, 3, 4
Loratadine and desloratadine are generally non-sedating at recommended doses but may cause sedation at higher doses or in patients with low body mass, and should be used at the lowest effective dose in elderly patients 1, 4

Intranasal corticosteroids, such as fluticasone propionate, are the most effective monotherapy for controlling all symptoms of allergic rhinitis, including sneezing, rhinorrhea, and nasal congestion, with minimal systemic absorption when used as directed 4, 5
Intranasal anticholinergics, such as ipratropium bromide, are specifically effective for rhinorrhea but have minimal effect on other symptoms, and may be particularly useful for persistent rhinorrhea 1, 5

The American College of Allergy, Asthma, and Immunology recommends fexofenadine at standard dose as first-line therapy, providing effective symptom relief without sedation and minimal cardiovascular and renal concerns 1, 3, 4
If there is an inadequate response to fexofenadine, adding an intranasal corticosteroid, such as fluticasone, can provide superior efficacy for all symptoms 4, 5
For predominant rhinorrhea that persists despite above treatment, considering adding an intranasal anticholinergic, such as ipratropium, can target rhinorrhea specifically without systemic effects 1, 5

The American Geriatrics Society recommends avoiding first-generation antihistamines entirely in elderly patients with cardiovascular and renal issues due to their significant risks 1, 3
Monitoring for drug interactions, especially with other CNS-active medications, and using the lowest effective dose of any medication is crucial 2, 4

Fexofenadine is a second-generation antihistamine that does not cause sedation at recommended doses and has minimal side effects compared to placebo 6
Eliminating pseudoephedrine removes potential side effects such as insomnia, irritability, palpitations, and elevated blood pressure that can occur with decongestants 6

Switch to Allegra alone when nasal congestion is no longer a predominant symptom 6
Consider switching if experiencing side effects from the pseudoephedrine component of Allegra D, such as insomnia or elevated blood pressure 6

If nasal congestion becomes problematic after switching to Allegra alone, discuss with your healthcare provider about possibly adding a different decongestant or using an intranasal corticosteroid 6

If nasal congestion persists after switching to Allegra alone, intranasal corticosteroids are typically the most effective medication for controlling all symptoms of allergic rhinitis, including congestion 6
Short-term use of topical decongestants (no more than 3 days) can help with acute nasal congestion, but prolonged use risks rhinitis medicamentosa (rebound congestion) 6
Nasal saline irrigation can provide some relief for nasal symptoms without medication-related side effects 6